The American Kidney Fund (AKF) is pleased to invite applicants for its Clinical Scientist in Nephrology (CSN) Program for academic year 2020. The application and related documents must reach AKF on or before November 22, 2019.
Please direct all inquiries to Professional Education at firstname.lastname@example.org or 800.638.8299.
Learn more about the Clinical Scientist in Nephrology (CSN) Program
For over 30 years, the American Kidney Fund Clinical Scientist in Nephrology (CSN) fellowship program has funded researchers whose work is designed to improve diagnosis, treatment and outcomes for patients living with chronic kidney disease (CKD) and has promoted clinical research in nephrology. Our CSN fellows conduct prevention and outcomes research while receiving advanced training in essential skills such as medical ethics, biostatistics and epidemiology.
The Clinical Scientist in Nephrology program has trained some of nephrology's brightest scholars who have gone on to become leaders in the field and mentors to new generations of scientists studying kidney disease. Many former CSN fellows have conducted groundbreaking research that advances knowledge and treatment of kidney disease.
A Clinical Scientist in Nephrology fellowship may be granted yearly, with a maximum duration of two years for each fellowship. The maximum level of funding of $80,000 per year shall be used principally to support the candidate and his or her career development. This sum is expected to cover the individual fellow's salary (not to exceed $55,000) as well as training-related expenses.
Meet our 2019 CSN fellows
Dr. O. Alison Potok
Dr. O. Alison Potok is currently a nephrology fellow at the University of California, San Diego. She was born and raised in Paris, France, and completed her medical school training at Université Paris V René Descartes and a family medicine residency at Faculté de Médecine de Strasbourg. She then moved to the United States and completed her internal medicine residency at the University of Pennsylvania Health System in Philadelphia. Throughout her years of training, Dr. Potok has cared for the elderly on multiple occasions and has developed a research interest in geriatric nephrology. Her research project consists in better understanding how two common markers used to estimate kidney function relate to aging and body composition. Clinicians usually estimate kidney function by calculating the glomerular filtration rate (GFR), using markers present in the blood, most commonly serum creatinine or cystatin C. Dr. Potok will study how differences in these estimates correlate with muscle mass and frailty in older adults. Dr. Potok’s AKF Clinical Scientist in Nephrology fellowship is funded by a grant from Akebia Therapeutics.
Dr. Pablo Garcia
Dr. Pablo Garcia is a second-year nephrology fellow at Stanford University. He was born and raised in Guatemala. He received his medical degree from the Universidad de San Carlos de Guatemala. He underwent clinical training in internal medicine at Rutgers/Saint Peter’s University Hospital in New Brunswick, New Jersey before joining Stanford’s fellowship program.
As the 2019-2020 American Kidney Fund Clinical Scientist in Nephrology fellow, Dr. Garcia’s research project is entitled Exploring the epidemiology and etiology of primary tubulointerstitial kidney disease, Dr. Garcia’s research seeks to better understand the causes and prognosis of primary tubulointerstitial kidney disease.
Dr. Garcia’s ultimate career goal is to become an academic nephrologist with focused interest and expertise in tubulointerstitial kidney disease and chronic kidney disease of unknown origin (CKDu).
Dr. Garcia’s AKF Clinical Scientist in Nephrology fellowship is funded in part by a grant from Amgen.
Meet our 2018-2019 CSN fellow
Katherine Wang, MD
Dr. Katherine Wang is currently a second-year nephrology fellow at Stanford University. She completed her undergraduate degree at the University of Rochester and her medical school and residency training in internal medicine at Albany Medical College.
As the 2018-2019 American Kidney Fund Clinical Scientist in Nephrology fellow, Dr. Wang’s research project is entitled SPRINTing to intensive blood pressure targets: when, for whom, and how?, will be an evaluation of the achievement of intensive blood pressure control in the Systolic Blood Pressure Intervention Trial (SPRINT).
“I am enthusiastic and earnest about this opportunity. I wholly believe in the American Kidney Fund’s commitment to fostering healthcare access, health literacy and prevention/progression of kidney disease,” said Dr. Wang.
Dr. Wang envisions an enriching career serving as an academic nephrologist. Her major interests are focused on improving hypertension outcomes, particularly in patients suffering with chronic kidney disease.